Serial Number | 90089895 |
Word Mark | COVID-SEROINDEX |
Filing Date | Monday, August 3, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, September 19, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 21, 2021 |
Goods and Services | Diagnostic agents, preparations and substances other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or medical research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting and analyzing antibodies, enzymes, antigens, diseases, viruses and infections for scientific, laboratory or medical research use; Test kits consisting of diagnostic preparations, reagents, assays, solutions and buffers for clinical or medical laboratory testing and analysis of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Test kits comprised of diagnostic preparations, reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection for scientific or medical research use; Diagnostic preparations for scientific or research purposes related to vaccines in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Diagnostic assays, media, solutions and buffers for clinical use; Diagnostic agents for carrying out serologic tests for clinical purposes; Diagnostic reagents for serologic tests of infections for clinical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for clinical and research purposes; Diagnostic preparations for clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19 |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, September 1, 2020 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Kantaro Biosciences LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | New York, NY 10036 |
Party Name | Kantaro Biosciences LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | New York, NY 10036 |
Event Date | Event Description |
Monday, September 19, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, September 19, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, February 15, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, December 21, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, December 21, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, December 1, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sunday, November 14, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, August 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, August 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, August 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, March 20, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, March 20, 2021 | NON-FINAL ACTION E-MAILED |
Saturday, March 20, 2021 | NON-FINAL ACTION WRITTEN |
Friday, February 26, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, February 26, 2021 | NON-FINAL ACTION E-MAILED |
Friday, February 26, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, February 10, 2021 | ASSIGNED TO EXAMINER |
Tuesday, September 1, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, August 6, 2020 | NEW APPLICATION ENTERED IN TRAM |